We are live on
!
Find out more
HVC
Healthcare Value Capital Portfolio holdings
AUM
$50.7M
1-Year Est. Return
24.72%
This Fund
S&P 500
This Quarter
Est. Return
+6.52%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$138M
AUM Growth
–
Cap. Flow
+$63.4M
Cap. Flow
% of AUM
45.95%
Top 10 Holdings %
Top 10 Hldgs %
47.95%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$4.38M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$4.25M |
| 3 |
AstraZeneca
AZN
|
+$4.19M |
| 4 |
Quest Diagnostics
DGX
|
+$4M |
| 5 |
Accuray
ARAY
|
+$3.42M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 60.07% |
| 2 | Healthcare | 39.54% |
| 3 | Industrials | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRTX
26
CALL
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
| $1.71M | 1.24% |
+213,100
| New | +$1.8M |
|
27
Sanofi
SNY
$107B
| $1.69M | 1.22% |
+32,735
| New | +$1.74M |
|
|
WCG
28
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.67M | 1.21% |
+30,000
| New | +$1.68M |
|
|
NUVA
29
DELISTED
NuVasive, Inc.
NUVA
| $1.63M | 1.18% |
+65,588
| New | +$1.44M |
|
|
QLTI
30
DELISTED
QLT Inc
QLTI
| $1.6M | 1.16% |
+365,139
| New | +$2.95M |
|
|
AGN
31
DELISTED
Allergan plc
AGN
| $1.58M | 1.15% |
+12,524
| New | +$1.42M |
|
|
HMA
32
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $1.57M | 1.14% |
+100,000
| New | +$1.26M |
|
|
GIVN
33
DELISTED
GIVEN IMAGING LTD
GIVN
| $1.54M | 1.12% |
+109,950
| New | +$1.67M |
|
|
MDCO
34
PUT
DELISTED
Medicines Co
MDCO
| $1.54M | 1.12% |
+50,000
| New | +$1.67M |
|
|
STJ
35
DELISTED
St Jude Medical
STJ
| $1.43M | 1.04% |
+31,349
| New | +$1.36M |
|
36
Pacira BioSciences
PCRX
$1.03B
| $1.3M | 0.95% |
+45,000
| New | +$1.3M |
|
|
37
CALL
Sanofi
SNY
$107B
| $1.29M | 0.93% |
+25,000
| New | +$1.33M |
|
38
CALL
GSK
GSK
$101B
| $1.25M | 0.91% |
+20,000
| New | +$1.27M |
|
|
39
CALL
AstraZeneca
AZN
$255B
| $1.18M | 0.86% |
+25,000
| New | +$1.27M |
|
40
CALL
Boston Scientific
BSX
$67.6B
| $927K | 0.67% |
+100,000
| New | +$848K |
|
|
CRTX
41
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
| $865K | 0.63% |
+108,168
| New | +$912K |
|
42
Merck
MRK
$369B
| $790K | 0.57% |
+17,816
| New | +$796K |
|
43
Cytokinetics
CYTK
$10.8B
| $771K | 0.56% |
+66,666
| New | +$525K |
|
|
SPPI
44
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $746K | 0.54% |
+100,000
| New | +$767K |
|
45
Artivion
AORT
$1.3B
| $740K | 0.54% |
+118,288
| New | +$722K |
|
|
VVUS
46
PUT
DELISTED
Vivus Inc
VVUS
| $629K | 0.46% |
+5,000
| New | +$645K |
|
|
ESRX
47
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $617K | 0.45% |
+10,000
| New | +$602K |
|
48
CALL
Vanda Pharmaceuticals
VNDA
$329M
| $606K | 0.44% |
+75,000
| New | +$505K |
|
|
SPPI
49
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $599K | 0.43% |
+80,315
| New | +$616K |
|
|
AH
50
DELISTED
Accretive Health
AH
| $531K | 0.39% |
+49,100
| New | +$517K |
|
Similar funds
C
CC
FCOI
FCOI
BI
KC
SCIM
MCP
Healthcare Value Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Healthcare Value Capital, which disclosed 56 positions worth $138M. Its ten largest holdings account for 48% of the portfolio.
Its largest position is AUXILIUM PHARAMCEUTICALS INC: 274,481 shares worth $4.57M.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, followed by Healthcare and Industrials.
- Healthcare Value Capital's largest Q2 2013 buy was AUXILIUM PHARAMCEUTICALS INC: 274,481 shares worth $4.57M.
- Healthcare Value Capital's ten largest holdings make up 48% of its $138M portfolio in Q2 2013.
- Healthcare Value Capital disclosed 56 positions in Q2 2013, its first 13F filing on record.
Based on Healthcare Value Capital's 13F filing for Q2 2013, filed 8 Aug 2013.